Abstract
Studies on the metabolism of the polysaccharide hyaluronan has previously been hampered by the lack of radioactive hyaluronan of high molecular weight (MW) and high specific activity. In the present study125I-tyrosine (T)-labelled hyaluronan was produced after CNBr-activation of the polysaccharide. A specific activity of approximately 0.1 MBq µg−1 was achieved using 100 µg of 0.5×106 Da hyaluronan labelled for 2 h with 18 MBq125I. The125I-T-hyaluronan kept a high MW-profile upon gel filtration chromatography and was found to be cleared from the circulation with the kinetics and organ distribution reported for biosynthetically labelled hyaluronan of high MW. The125I-labelled polysaccharide is also taken up by liver endothelial cells bothin vivo andin vitro, indicating that the labelling does not interfere with the binding to specific cell-surface receptors found on these cells. The intracellular degradation is slower than that earlier reported for biosynthetically labelled hyaluronan and seems to be halted at the level of low MW oligo- or mono-saccharides that eventually leave the organism via the urine. Scintigraphic images of rats after intravenous injection of125I-T-hyaluronan showed rapid uptake in the liver and a redistribution of radioactivity from liver to urine with time. Our results indicate that the125I-T-hyaluronan is suitable for studies of hyaluronan-metabolism in a number of ways. The gamma emitters125I and131I are easy to monitor and can be used also forin vivo 3D-imaging using single photon emission computer tomography.
Similar content being viewed by others
Abbreviations
- CNBr:
-
cyanogen bromide
- T-HA:
-
tyrosine-labelled hyaluronan
References
Eriksson S, Fraser JRE, Laurent TC, Pertoft H, Smedsrød B (1983)Exp Cell Res 144:223–28.
Fraser JRE, Laurent TC (1989) InThe Biology of Hyaluronan (Evered D, Whelan J eds) pp. 41–52. Chichester: Wiley.
Forsberg N, Gustafson S (1991)Biochim Biophys Acta 1078:12–18.
Knudson CB, Knudson W (1993)Faseb J 7:1233–41.
Raja RH, LeBoeuf RD, Stone GW, Weigel PH (1984)Anal Biochem 139:168–77.
Dahl B, Laurent TC, Smedsrød B (1988)Anal Biochem 175:397–407.
Gustafson S, Forsberg N, McCourt P, Wikström T, Björkman T, Lilja K (1994) InFirst International Workshop on Hyaluronan in Drug Delivery (Willoughby DA ed.) pp. 43–59. London: Medicine Press Ltd.
Lebel L, Smith L, Risberg B, Laurent TC, Gerdin B (1989)Am J Physiol 256 (Heart Circ Physiol 25):H1524–31.
Pertoft H, Smedsrød B (1987) InMethods and Selected Applications (Pretlow TG, Pretlow TP, eds) pp. 1–24. New York: Academic Press.
Smedsrød B, Pertoft H, Gustafson S, Laurent TC (1990)Biochem J 266:313–27.
Glabe CG, Harty PK, Rosen SD (1983)Anal Biochem 130:287–94.
Gustafson S, Östlund-Lindqvist A-M, Vessby B (1985)Biochem Biophys Acta 834:308–15.
Knook DL, Sleyster C (1976)Exp Cell Res 99:444–49.
Smedsrød B, Pertoft H, Eriksson S, Fraser JRE, Laurent TC (1984)Biochem J 223:617–26.
Fraser JRE, Laurent TC, Pertoft H, Baxter E (1981)Biochem J 200:415–24.
Fraser JRE, Alcorn D, Laurent TC, Robinson AD, Ryan GB (1985)Cell Tissue Res 242:505–10.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gustafson, S., Björkman, T. & Westlin, JE. Labelling of high molecular weight hyaluronan with125I-tyrosine: studiesin vitro andin vivo in the rat. Glycoconjugate J 11, 608–613 (1994). https://doi.org/10.1007/BF00731313
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00731313